| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.37e-12 | 28 | 106 | 8 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.01e-11 | 35 | 106 | 8 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.53e-10 | 48 | 106 | 8 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.82e-10 | 49 | 106 | 8 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.02e-07 | 107 | 106 | 8 | GO:0033293 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TYMP UGT1A4 UGT1A1 UGT1A3 DPY19L4 | 1.85e-07 | 211 | 106 | 10 | GO:0016758 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.58e-06 | 153 | 106 | 8 | GO:0008194 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TYMP UGT1A4 UGT1A1 UGT1A3 DPY19L4 | 3.14e-06 | 288 | 106 | 10 | GO:0016757 |
| GeneOntologyMolecularFunction | carboxylic acid binding | UBR2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.20e-06 | 239 | 106 | 9 | GO:0031406 |
| GeneOntologyMolecularFunction | steroid binding | 6.99e-06 | 133 | 106 | 7 | GO:0005496 | |
| GeneOntologyMolecularFunction | organic acid binding | UBR2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.49e-06 | 254 | 106 | 9 | GO:0043177 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SRGAP2 UGT1A4 UGT1A1 UGT1A3 SRGAP2C TENM4 | 8.77e-06 | 398 | 106 | 11 | GO:0046982 |
| GeneOntologyMolecularFunction | protein homodimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 TRPC6 SRM UGT1A9 SRGAP2 TYMP UGT1A4 UGT1A1 UGT1A3 SRGAP2C TENM4 | 1.03e-04 | 815 | 106 | 14 | GO:0042803 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.12e-04 | 18 | 106 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 3.46e-04 | 26 | 106 | 3 | GO:0004806 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.20e-04 | 66 | 106 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.32e-04 | 28 | 106 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.98e-04 | 69 | 106 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | lipase activity | 8.50e-04 | 138 | 106 | 5 | GO:0016298 | |
| GeneOntologyMolecularFunction | lipoprotein lipase activity | 9.81e-04 | 9 | 106 | 2 | GO:0004465 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.91e-04 | 37 | 106 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | actinin binding | 1.54e-03 | 43 | 106 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | protein dimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 TRPC6 SRM UGT1A9 SRGAP2 TYMP UGT1A4 UGT1A1 UGT1A3 SRGAP2C TENM4 ZBED6 | 1.73e-03 | 1205 | 106 | 15 | GO:0046983 |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.78e-03 | 12 | 106 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.44e-03 | 14 | 106 | 2 | GO:0070679 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 6.62e-14 | 21 | 105 | 8 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.98e-13 | 26 | 105 | 8 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.98e-13 | 26 | 105 | 8 | GO:0006063 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 3.11e-12 | 5 | 105 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.86e-11 | 6 | 105 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.51e-11 | 13 | 105 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.39e-09 | 12 | 105 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.16e-09 | 5 | 105 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 9.44e-09 | 6 | 105 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 9.44e-09 | 6 | 105 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.30e-07 | 10 | 105 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.30e-07 | 10 | 105 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.54e-07 | 52 | 105 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.77e-06 | 40 | 105 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.55e-06 | 21 | 105 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 8.54e-06 | 94 | 105 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 2.57e-05 | 2 | 105 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 2.57e-05 | 2 | 105 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.61e-05 | 34 | 105 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | negative regulation of dendrite morphogenesis | 2.73e-05 | 12 | 105 | 3 | GO:0050774 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.47e-05 | 141 | 105 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 9.18e-05 | 89 | 105 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.19e-04 | 94 | 105 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.84e-04 | 309 | 105 | 8 | GO:1901888 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.00e-04 | 105 | 105 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 2.54e-04 | 5 | 105 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.80e-04 | 67 | 105 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 5.00e-04 | 72 | 105 | 4 | GO:0022029 | |
| GeneOntologyBiologicalProcess | cell motility involved in cerebral cortex radial glia guided migration | 5.30e-04 | 7 | 105 | 2 | GO:0021814 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 5.84e-04 | 75 | 105 | 4 | GO:0021885 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 7.52e-04 | 382 | 105 | 8 | GO:0016042 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 8.53e-04 | 144 | 105 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | cornification | 9.03e-04 | 9 | 105 | 2 | GO:0070268 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 9.03e-04 | 9 | 105 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.64e-04 | 222 | 105 | 6 | GO:0071466 | |
| Domain | UDPGT | 2.30e-13 | 21 | 111 | 8 | PF00201 | |
| Domain | UDPGT | 2.30e-13 | 21 | 111 | 8 | PS00375 | |
| Domain | UDP_glucos_trans | 2.30e-13 | 21 | 111 | 8 | IPR002213 | |
| Domain | srGAP2 | 2.04e-07 | 3 | 111 | 3 | IPR030252 | |
| Domain | Lipase_euk | 4.03e-06 | 6 | 111 | 3 | IPR025483 | |
| Domain | Abhydro_lipase | 4.03e-06 | 6 | 111 | 3 | PF04083 | |
| Domain | AB_hydrolase_lipase | 4.03e-06 | 6 | 111 | 3 | IPR006693 | |
| Domain | FCH | 7.96e-06 | 22 | 111 | 4 | PF00611 | |
| Domain | FCH | 7.96e-06 | 22 | 111 | 4 | SM00055 | |
| Domain | FCH_dom | 9.59e-06 | 23 | 111 | 4 | IPR001060 | |
| Domain | F_BAR | 1.36e-05 | 25 | 111 | 4 | IPR031160 | |
| Domain | F_BAR | 1.36e-05 | 25 | 111 | 4 | PS51741 | |
| Domain | Dynein_HC_stalk | 7.09e-05 | 14 | 111 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.09e-05 | 14 | 111 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.09e-05 | 14 | 111 | 3 | PF08393 | |
| Domain | MT | 7.09e-05 | 14 | 111 | 3 | PF12777 | |
| Domain | DHC_fam | 8.82e-05 | 15 | 111 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 8.82e-05 | 15 | 111 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.82e-05 | 15 | 111 | 3 | IPR004273 | |
| Domain | DP | 1.05e-04 | 3 | 111 | 2 | PF08781 | |
| Domain | Transcrpt_fac_DP | 1.05e-04 | 3 | 111 | 2 | IPR015648 | |
| Domain | Transc_factor_DP_C | 1.05e-04 | 3 | 111 | 2 | IPR014889 | |
| Domain | DP | 1.05e-04 | 3 | 111 | 2 | SM01138 | |
| Domain | NUT | 3.46e-04 | 5 | 111 | 2 | IPR024310 | |
| Domain | NUT_N | 3.46e-04 | 5 | 111 | 2 | IPR024309 | |
| Domain | NUT | 3.46e-04 | 5 | 111 | 2 | PF12881 | |
| Domain | LIPASE_SER | 4.81e-04 | 26 | 111 | 3 | PS00120 | |
| Domain | TRP_2 | 5.17e-04 | 6 | 111 | 2 | PF08344 | |
| Domain | TRP_dom | 5.17e-04 | 6 | 111 | 2 | IPR013555 | |
| Domain | TLV_coat | 7.21e-04 | 7 | 111 | 2 | PF00429 | |
| Domain | TRPC_channel | 7.21e-04 | 7 | 111 | 2 | IPR002153 | |
| Domain | Abhydrolase_1 | 8.13e-04 | 31 | 111 | 3 | PF00561 | |
| Domain | DHC_N1 | 9.57e-04 | 8 | 111 | 2 | PF08385 | |
| Domain | TLV/ENV_coat_polyprotein | 9.57e-04 | 8 | 111 | 2 | IPR018154 | |
| Domain | Dynein_heavy_dom-1 | 9.57e-04 | 8 | 111 | 2 | IPR013594 | |
| Domain | AB_hydrolase_1 | 9.79e-04 | 33 | 111 | 3 | IPR000073 | |
| Domain | EF-hand_4 | 1.53e-03 | 10 | 111 | 2 | PF12763 | |
| Domain | SH3 | 1.84e-03 | 216 | 111 | 6 | PS50002 | |
| Domain | TRP_channel | 1.86e-03 | 11 | 111 | 2 | IPR004729 | |
| Domain | E2F_TDP | 1.86e-03 | 11 | 111 | 2 | PF02319 | |
| Domain | EH | 1.86e-03 | 11 | 111 | 2 | PS50031 | |
| Domain | E2F_TDP | 1.86e-03 | 11 | 111 | 2 | SM01372 | |
| Domain | EH | 1.86e-03 | 11 | 111 | 2 | SM00027 | |
| Domain | E2F_WHTH_DNA-bd_dom | 1.86e-03 | 11 | 111 | 2 | IPR003316 | |
| Domain | EH_dom | 1.86e-03 | 11 | 111 | 2 | IPR000261 | |
| Domain | SH3_domain | 2.02e-03 | 220 | 111 | 6 | IPR001452 | |
| Domain | PROTEIN_KINASE_TYR | 2.68e-03 | 97 | 111 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.68e-03 | 97 | 111 | 4 | IPR008266 | |
| Domain | DEATH-like_dom | 2.88e-03 | 99 | 111 | 4 | IPR011029 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.04e-03 | 14 | 111 | 2 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 3.04e-03 | 14 | 111 | 2 | IPR011704 | |
| Domain | AAA_8 | 3.04e-03 | 14 | 111 | 2 | PF12780 | |
| Domain | AAA_5 | 3.04e-03 | 14 | 111 | 2 | PF07728 | |
| Domain | EGF_extracell | 5.47e-03 | 60 | 111 | 3 | IPR013111 | |
| Domain | EGF_2 | 5.47e-03 | 60 | 111 | 3 | PF07974 | |
| Domain | - | 5.56e-03 | 119 | 111 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 5.56e-03 | 119 | 111 | 4 | IPR029058 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | CES5A UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TYMP UGT1A4 UGT1A1 UGT1A3 | 1.80e-13 | 51 | 79 | 10 | M17726 |
| Pathway | REACTOME_GLUCURONIDATION | 4.63e-13 | 24 | 79 | 8 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.77e-13 | 25 | 79 | 8 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 6.77e-13 | 25 | 79 | 8 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 6.77e-13 | 25 | 79 | 8 | M605 | |
| Pathway | WP_GLUCURONIDATION | 9.74e-13 | 26 | 79 | 8 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.92e-12 | 28 | 79 | 8 | M19580 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.11e-11 | 22 | 79 | 7 | MM15888 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.57e-11 | 41 | 79 | 8 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.23e-10 | 45 | 79 | 8 | MM15694 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.17e-10 | 52 | 79 | 8 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.66e-10 | 55 | 79 | 8 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.33e-09 | 64 | 79 | 8 | M9488 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.29e-09 | 44 | 79 | 7 | M45014 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.83e-09 | 70 | 79 | 8 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.07e-09 | 72 | 79 | 8 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SLC29A2 UGT1A4 UGT1A1 UGT1A3 | 9.27e-09 | 109 | 79 | 9 | M45012 |
| Pathway | REACTOME_DRUG_ADME | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SLC29A2 UGT1A4 UGT1A1 UGT1A3 | 2.01e-08 | 119 | 79 | 9 | MM15692 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.41e-07 | 107 | 79 | 8 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.63e-07 | 109 | 79 | 8 | M18788 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 8.76e-07 | 14 | 79 | 4 | M39328 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.18e-06 | 153 | 79 | 8 | MM15844 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.41e-06 | 39 | 79 | 5 | MM15695 | |
| Pathway | REACTOME_HEME_DEGRADATION | 4.13e-06 | 20 | 79 | 4 | MM14721 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.65e-05 | 145 | 79 | 7 | M45512 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.92e-05 | 32 | 79 | 4 | MM14719 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.02e-05 | 219 | 79 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.12e-05 | 220 | 79 | 8 | M10320 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 3.59e-05 | 12 | 79 | 3 | M39611 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.30e-05 | 183 | 79 | 7 | M39588 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 7.34e-05 | 15 | 79 | 3 | MM15697 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.14e-04 | 45 | 79 | 4 | M39615 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.30e-04 | 18 | 79 | 3 | M39424 | |
| Pathway | WP_NRF2_PATHWAY | 1.37e-04 | 141 | 79 | 6 | M39454 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.09e-04 | 21 | 79 | 3 | M39631 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.77e-04 | 23 | 79 | 3 | MM16639 | |
| Pathway | REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.07e-04 | 5 | 79 | 2 | M26903 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 4.58e-04 | 6 | 79 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 4.58e-04 | 6 | 79 | 2 | M39600 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.02e-04 | 28 | 79 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.02e-04 | 28 | 79 | 3 | M27241 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.57e-04 | 29 | 79 | 3 | M45015 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 7.47e-04 | 32 | 79 | 3 | M39567 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 8.49e-04 | 8 | 79 | 2 | M27349 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.09e-03 | 9 | 79 | 2 | M26946 | |
| Pathway | REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE | 1.24e-03 | 38 | 79 | 3 | M39005 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 1.36e-03 | 10 | 79 | 2 | M27330 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.90e-03 | 44 | 79 | 3 | M875 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 2.30e-03 | 47 | 79 | 3 | M29724 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 2.32e-03 | 13 | 79 | 2 | M1015 | |
| Pubmed | 9.31e-20 | 9 | 114 | 8 | 22511988 | ||
| Pubmed | 4.64e-19 | 10 | 114 | 8 | 23642732 | ||
| Pubmed | 4.64e-19 | 10 | 114 | 8 | 11465080 | ||
| Pubmed | 4.64e-19 | 10 | 114 | 8 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 4.64e-19 | 10 | 114 | 8 | 22558097 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.37e-18 | 7 | 114 | 7 | 8467709 | |
| Pubmed | 3.37e-18 | 7 | 114 | 7 | 8464825 | ||
| Pubmed | 5.08e-18 | 12 | 114 | 8 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.08e-18 | 12 | 114 | 8 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.32e-17 | 13 | 114 | 8 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.32e-17 | 13 | 114 | 8 | 25246029 | |
| Pubmed | 2.69e-17 | 8 | 114 | 7 | 17179145 | ||
| Pubmed | 2.69e-17 | 8 | 114 | 7 | 20610558 | ||
| Pubmed | 3.07e-17 | 14 | 114 | 8 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.07e-17 | 14 | 114 | 8 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 3.07e-17 | 14 | 114 | 8 | 14672974 | |
| Pubmed | 3.07e-17 | 14 | 114 | 8 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.31e-16 | 16 | 114 | 8 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.46e-16 | 17 | 114 | 8 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 7.61e-16 | 19 | 114 | 8 | 23281178 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.63e-15 | 12 | 114 | 7 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 7.31e-15 | 24 | 114 | 8 | 24625756 | |
| Pubmed | 3.02e-14 | 8 | 114 | 6 | 18052087 | ||
| Pubmed | 9.05e-14 | 9 | 114 | 6 | 1339448 | ||
| Pubmed | 3.46e-13 | 5 | 114 | 5 | 15057901 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 2.07e-12 | 6 | 114 | 5 | 19204906 | |
| Pubmed | 2.07e-12 | 6 | 114 | 5 | 20297805 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.50e-11 | 57 | 114 | 8 | 21886157 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.92e-11 | 8 | 114 | 5 | 12695355 | |
| Pubmed | 1.95e-11 | 18 | 114 | 6 | 20056724 | ||
| Pubmed | 5.09e-11 | 66 | 114 | 8 | 19898482 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 1.09e-10 | 4 | 114 | 4 | 18223459 | |
| Pubmed | 1.09e-10 | 4 | 114 | 4 | 9535849 | ||
| Pubmed | 1.09e-10 | 4 | 114 | 4 | 9271343 | ||
| Pubmed | 1.09e-10 | 4 | 114 | 4 | 17558305 | ||
| Pubmed | 1.63e-09 | 6 | 114 | 4 | 32527940 | ||
| Pubmed | 3.80e-09 | 7 | 114 | 4 | 27514509 | ||
| Pubmed | 7.59e-09 | 8 | 114 | 4 | 22579593 | ||
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TYMP UGT1A4 UGT1A1 UGT1A3 | 1.42e-08 | 190 | 114 | 9 | 24816252 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 22559944 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19364970 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 29519853 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 16636344 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 11179460 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 26247833 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 12051676 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 3.43e-08 | 3 | 114 | 3 | 24453052 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23789755 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 17406868 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19996319 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19303655 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 12847094 | ||
| Pubmed | 3.55e-08 | 11 | 114 | 4 | 18695635 | ||
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 18161889 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 1.37e-07 | 4 | 114 | 3 | 22559943 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 1634050 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 1898728 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 20628391 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 15855726 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 8276413 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.37e-07 | 4 | 114 | 3 | 2108603 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 8280139 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 3.41e-07 | 5 | 114 | 3 | 18597651 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 26010150 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 7677729 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 20565459 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 5.10e-07 | 211 | 114 | 8 | 24097068 | |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 15319294 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 10748067 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 18719240 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 2.84e-06 | 9 | 114 | 3 | 20732626 | |
| Pubmed | 7.13e-06 | 214 | 114 | 7 | 22199357 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 7.38e-06 | 12 | 114 | 3 | 19349540 | |
| Pubmed | 8.28e-06 | 407 | 114 | 9 | 12693553 | ||
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 1.07e-05 | 2 | 114 | 2 | 15864130 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15929176 | ||
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 1.07e-05 | 2 | 114 | 2 | 31132973 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 38165568 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9627603 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9639672 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9621515 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8226884 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18675828 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18349289 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10946897 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8068691 | ||
| Pubmed | Elucidation of a TRPC6-TRPC5 channel cascade that restricts endothelial cell movement. | 1.07e-05 | 2 | 114 | 2 | 18495872 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18981166 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 33984363 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25547628 | ||
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 1.07e-05 | 2 | 114 | 2 | 7715297 | |
| Pubmed | Store-operated Ca2+ entry in first trimester and term human placenta. | 1.07e-05 | 2 | 114 | 2 | 12766233 | |
| Pubmed | Increased UGT1A3 and UGT1A7 expression is associated with pancreatic cancer. | 1.07e-05 | 2 | 114 | 2 | 25743847 | |
| Pubmed | Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. | 1.07e-05 | 2 | 114 | 2 | 7989045 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8706880 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24641623 | ||
| Pubmed | Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy. | 1.07e-05 | 2 | 114 | 2 | 35480629 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 7906695 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31822692 | ||
| Pubmed | Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. | 1.07e-05 | 2 | 114 | 2 | 15286088 | |
| Interaction | UGT1A9 interactions | 5.58e-07 | 13 | 109 | 4 | int:UGT1A9 | |
| Cytoband | 2q37 | 8.47e-15 | 31 | 114 | 8 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 CAPN10 UGT1A4 UGT1A1 UGT1A3 | 5.99e-09 | 226 | 114 | 9 | chr2q37 |
| Cytoband | 10q23.31 | 8.44e-05 | 34 | 114 | 3 | 10q23.31 | |
| Cytoband | 6p21.1 | 1.07e-03 | 80 | 114 | 3 | 6p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.46e-03 | 195 | 114 | 4 | chr10q23 | |
| Cytoband | 9q31.3 | 1.49e-03 | 23 | 114 | 2 | 9q31.3 | |
| Cytoband | 12q24.11 | 3.07e-03 | 33 | 114 | 2 | 12q24.11 | |
| GeneFamily | UDP glucuronosyltransferases | 1.48e-12 | 32 | 84 | 8 | 363 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.59e-06 | 23 | 84 | 4 | 1288 | |
| GeneFamily | Transcription factor Dp family | 6.38e-05 | 3 | 84 | 2 | 987 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 1.40e-04 | 22 | 84 | 3 | 464 | |
| GeneFamily | Transient receptor potential cation channels | 2.91e-04 | 28 | 84 | 3 | 249 | |
| CoexpressionAtlas | parathyroid gland | SLC36A1 ADAM23 CD109 SALL4 SRGAP2C KL TENM4 RIMBP2 ADGRL3 NLRP5 | 1.32e-05 | 347 | 110 | 10 | parathyroid gland |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STAB2 OBSCN SALL4 TENM4 TRPM3 ROS1 ZNF488 DNAH5 ADGRL3 EPHA10 | 4.82e-11 | 184 | 114 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STAB2 OBSCN SALL4 TENM4 TRPM3 ROS1 ZNF488 DNAH5 ADGRL3 EPHA10 | 4.82e-11 | 184 | 114 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STAB2 OBSCN SALL4 TENM4 TRPM3 ROS1 ZNF488 DNAH5 ADGRL3 EPHA10 | 4.82e-11 | 184 | 114 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 6.24e-07 | 191 | 114 | 7 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 6.24e-07 | 191 | 114 | 7 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-07 | 192 | 114 | 7 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.93e-07 | 194 | 114 | 7 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.17e-07 | 195 | 114 | 7 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.68e-07 | 197 | 114 | 7 | a902aa05e5f711bcfdd9e19749ab636b597eb116 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-06 | 179 | 114 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 8.74e-06 | 187 | 114 | 6 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 9.86e-06 | 191 | 114 | 6 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 1.02e-05 | 192 | 114 | 6 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 194 | 114 | 6 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-05 | 196 | 114 | 6 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.94e-05 | 155 | 114 | 5 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 169 | 114 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-05 | 172 | 114 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 178 | 114 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | 9d7e39357b269d30ff1e8007a91f8645f3d80e73 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-05 | 179 | 114 | 5 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | 1611e11f5f74432627e2f57a27e352b1e46be618 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 180 | 114 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 180 | 114 | 5 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 180 | 114 | 5 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 180 | 114 | 5 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 114 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 114 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 114 | 5 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 185 | 114 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 185 | 114 | 5 | 0a87d2ee8fffc812224c05a26c729733a5e64d2c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 185 | 114 | 5 | e63fde030be822ebf32143a41f8cc684cb720f5b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 186 | 114 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-04 | 187 | 114 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-04 | 188 | 114 | 5 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.26e-04 | 189 | 114 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-04 | 190 | 114 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 190 | 114 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-04 | 190 | 114 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 1.29e-04 | 190 | 114 | 5 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.32e-04 | 191 | 114 | 5 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.35e-04 | 192 | 114 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 193 | 114 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 193 | 114 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 194 | 114 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-04 | 194 | 114 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.42e-04 | 194 | 114 | 5 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 194 | 114 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-04 | 195 | 114 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 195 | 114 | 5 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-04 | 195 | 114 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-04 | 195 | 114 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.45e-04 | 195 | 114 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.45e-04 | 195 | 114 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-04 | 195 | 114 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.49e-04 | 196 | 114 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-04 | 196 | 114 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.49e-04 | 196 | 114 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.49e-04 | 196 | 114 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.49e-04 | 196 | 114 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-04 | 197 | 114 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-04 | 197 | 114 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 1.53e-04 | 197 | 114 | 5 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 197 | 114 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 197 | 114 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.56e-04 | 198 | 114 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-04 | 198 | 114 | 5 | 979c391a3b7130e4f91d76a9eb8079fb0f445c4c | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.60e-04 | 199 | 114 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| Drug | AC1MRQNQ | 2.38e-18 | 9 | 112 | 8 | CID003522271 | |
| Drug | DHPASiU | 2.38e-18 | 9 | 112 | 8 | CID000197602 | |
| Drug | Chebi:32663 | 2.38e-18 | 9 | 112 | 8 | CID005460873 | |
| Drug | 3-iodophenol | 2.38e-18 | 9 | 112 | 8 | CID000012272 | |
| Drug | AC1L4J7U | 2.38e-18 | 9 | 112 | 8 | CID000186631 | |
| Drug | 4-nitrophenyl)imidazole | 4.33e-17 | 11 | 112 | 8 | CID000123155 | |
| Drug | AC1O5XMV | 4.33e-17 | 11 | 112 | 8 | CID006442661 | |
| Drug | N-OH-DABZ | 1.29e-16 | 12 | 112 | 8 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.29e-16 | 12 | 112 | 8 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.29e-16 | 12 | 112 | 8 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.29e-16 | 12 | 112 | 8 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 1.29e-16 | 12 | 112 | 8 | CID000160090 | |
| Drug | tritanol | 3.35e-16 | 13 | 112 | 8 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.35e-16 | 13 | 112 | 8 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 3.35e-16 | 13 | 112 | 8 | CID000000411 | |
| Drug | propranolol glucuronide | 7.79e-16 | 14 | 112 | 8 | CID000119515 | |
| Drug | PCB-61 | 7.79e-16 | 14 | 112 | 8 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.66e-15 | 15 | 112 | 8 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 1.66e-15 | 15 | 112 | 8 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.66e-15 | 15 | 112 | 8 | CID000543743 | |
| Drug | afloqualone | 1.66e-15 | 15 | 112 | 8 | CID000002040 | |
| Drug | naphthyl sulphate | 1.66e-15 | 15 | 112 | 8 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 3.31e-15 | 16 | 112 | 8 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 3.31e-15 | 16 | 112 | 8 | CID000040003 | |
| Drug | bilirubin-phosphate | 3.31e-15 | 16 | 112 | 8 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 6.23e-15 | 17 | 112 | 8 | CID000003573 | |
| Drug | 6-hydroxychrysene | 6.23e-15 | 17 | 112 | 8 | CID000037766 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.12e-14 | 18 | 112 | 8 | CID000152226 | |
| Drug | Br 2 | 1.12e-14 | 18 | 112 | 8 | CID003060900 | |
| Drug | SureCN12722713 | 1.12e-14 | 18 | 112 | 8 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.12e-14 | 18 | 112 | 8 | CID000036614 | |
| Drug | ApApG | 1.12e-14 | 18 | 112 | 8 | CID003081975 | |
| Drug | C1 11-32 | 1.12e-14 | 18 | 112 | 8 | CID000443077 | |
| Drug | C11131 | 1.12e-14 | 18 | 112 | 8 | CID000443076 | |
| Drug | trans-3'-hydroxycotinine | 1.12e-14 | 29 | 112 | 9 | CID000000414 | |
| Drug | almokalant | 1.92e-14 | 19 | 112 | 8 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.92e-14 | 19 | 112 | 8 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.92e-14 | 19 | 112 | 8 | CID000091433 | |
| Drug | tectochrysin | 3.19e-14 | 20 | 112 | 8 | CID005281954 | |
| Drug | AC1L1OBF | 3.19e-14 | 20 | 112 | 8 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 3.19e-14 | 20 | 112 | 8 | CID000116545 | |
| Drug | estriol-16-glucuronide | 5.13e-14 | 21 | 112 | 8 | CID000122281 | |
| Drug | dulcin | 5.13e-14 | 21 | 112 | 8 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 5.13e-14 | 21 | 112 | 8 | CID000069186 | |
| Drug | AC1NOWCJ | 7.71e-14 | 35 | 112 | 9 | CID005120112 | |
| Drug | amonafide | 8.03e-14 | 22 | 112 | 8 | CID000050515 | |
| Drug | N-methylpiperazine | 8.03e-14 | 22 | 112 | 8 | CID000053167 | |
| Drug | amidoxime | 1.23e-13 | 23 | 112 | 8 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.23e-13 | 23 | 112 | 8 | CID000066651 | |
| Drug | phenanthridine | 1.23e-13 | 23 | 112 | 8 | CID000009189 | |
| Drug | 4-methylumbelliferyl glucuronide | 1.76e-13 | 38 | 112 | 9 | CID000091553 | |
| Drug | AS-3201 | 1.83e-13 | 24 | 112 | 8 | CID000153948 | |
| Drug | 5-MOP | 2.68e-13 | 25 | 112 | 8 | CID000002355 | |
| Drug | AzMC | 2.68e-13 | 25 | 112 | 8 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.68e-13 | 25 | 112 | 8 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.68e-13 | 25 | 112 | 8 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.68e-13 | 25 | 112 | 8 | CID000013662 | |
| Drug | DiMeIQx | 5.46e-13 | 27 | 112 | 8 | CID000104739 | |
| Drug | diflunisal | 5.46e-13 | 27 | 112 | 8 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 7.62e-13 | 28 | 112 | 8 | CID000081261 | |
| Drug | CARMINE | 7.62e-13 | 28 | 112 | 8 | CID000014749 | |
| Drug | erucin | 7.62e-13 | 28 | 112 | 8 | CID000078160 | |
| Drug | H-Ni | 7.62e-13 | 28 | 112 | 8 | CID000445665 | |
| Drug | AC1L1JAL | 1.05e-12 | 29 | 112 | 8 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.05e-12 | 29 | 112 | 8 | CID005375667 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.05e-12 | 29 | 112 | 8 | CID000125641 | |
| Drug | iberin | 1.05e-12 | 29 | 112 | 8 | CID000010455 | |
| Drug | tolcapone | 1.42e-12 | 30 | 112 | 8 | CID004659569 | |
| Drug | paricalcitol | 1.42e-12 | 30 | 112 | 8 | CID005281104 | |
| Drug | AC1L9E0Q | 1.42e-12 | 30 | 112 | 8 | CID000443095 | |
| Drug | dihydroartemisinin | 1.42e-12 | 30 | 112 | 8 | CID000107770 | |
| Drug | 1-hydroxypyrene | 1.74e-12 | 48 | 112 | 9 | CID000021387 | |
| Drug | 4-ethylphenol | 1.91e-12 | 31 | 112 | 8 | CID000031242 | |
| Drug | PCB 156 | 1.91e-12 | 31 | 112 | 8 | CID000038019 | |
| Drug | 4'-HPPH | 1.91e-12 | 31 | 112 | 8 | CID000017732 | |
| Drug | indole-2-carboxylic acid | 2.54e-12 | 32 | 112 | 8 | CID000072899 | |
| Drug | NNAL | 2.54e-12 | 32 | 112 | 8 | CID000104856 | |
| Drug | Muracein C | 2.54e-12 | 32 | 112 | 8 | CID003086323 | |
| Drug | Glucuronides | 2.56e-12 | 10 | 112 | 6 | ctd:D020719 | |
| Drug | naringenin chalcone | 2.63e-12 | 5 | 112 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 2.63e-12 | 5 | 112 | 5 | ctd:C032186 | |
| Drug | AC1Q6OQG | 3.33e-12 | 33 | 112 | 8 | CID000009686 | |
| Drug | R(-)-Denopamine | 3.33e-12 | 33 | 112 | 8 | CID000003818 | |
| Drug | 6-methylsalicylic acid | 3.33e-12 | 33 | 112 | 8 | CID000011279 | |
| Drug | BP-3,6-quinol | 3.33e-12 | 33 | 112 | 8 | CID000119292 | |
| Drug | norbuprenorphine | 3.33e-12 | 33 | 112 | 8 | CID000114976 | |
| Drug | geniposide | 3.33e-12 | 33 | 112 | 8 | CID000107848 | |
| Drug | AC1NQGK1 | 3.75e-12 | 52 | 112 | 9 | CID005195977 | |
| Drug | capecitabine | UGT1A10 UGT1A8 UGT1A7 UGT1A5 LIPF UGT1A9 TYMP UGT1A4 UGT1A1 UGT1A3 LIPM | 3.76e-12 | 104 | 112 | 11 | CID000060953 |
| Drug | estragole | 4.34e-12 | 34 | 112 | 8 | CID000008815 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.61e-12 | 35 | 112 | 8 | CID010436171 | |
| Drug | estrone-3-glucuronide | 5.61e-12 | 35 | 112 | 8 | CID000115255 | |
| Drug | AC1L9DGV | 7.18e-12 | 36 | 112 | 8 | CID000417381 | |
| Drug | muraglitazar | 7.18e-12 | 36 | 112 | 8 | CID000206044 | |
| Drug | anisole | 7.18e-12 | 36 | 112 | 8 | CID000007519 | |
| Drug | glucoraphanin | 7.18e-12 | 36 | 112 | 8 | CID000656556 | |
| Drug | bevirimat | 7.18e-12 | 36 | 112 | 8 | CID000457928 | |
| Drug | acotiamide | 9.12e-12 | 37 | 112 | 8 | CID005282338 | |
| Drug | N-Fg | 9.12e-12 | 37 | 112 | 8 | CID000445227 | |
| Drug | l-borneol | 9.12e-12 | 37 | 112 | 8 | CID000010049 | |
| Disease | X-11442 measurement | 2.05e-19 | 9 | 107 | 8 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.05e-19 | 9 | 107 | 8 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.05e-19 | 9 | 107 | 8 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.05e-19 | 9 | 107 | 8 | EFO_0004570, GO_0009410 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.02e-18 | 10 | 107 | 8 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 1.02e-18 | 10 | 107 | 8 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 3.74e-18 | 11 | 107 | 8 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 3.74e-18 | 11 | 107 | 8 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 3.74e-18 | 11 | 107 | 8 | EFO_0800972 | |
| Disease | aldosterone measurement | 3.74e-18 | 11 | 107 | 8 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.12e-17 | 12 | 107 | 8 | EFO_0021033 | |
| Disease | X-11793--oxidized bilirubin measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0021260 | |
| Disease | Succinimide measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0022118 | |
| Disease | X-11530 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0800696 | |
| Disease | X-10458 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0800692 | |
| Disease | X-24849 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0802740 | |
| Disease | X-16946 measurement | 5.39e-17 | 8 | 107 | 7 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.42e-16 | 9 | 107 | 7 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.42e-16 | 9 | 107 | 7 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.42e-16 | 9 | 107 | 7 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.42e-16 | 9 | 107 | 7 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.42e-16 | 9 | 107 | 7 | EFO_0020691 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 5.42e-16 | 17 | 107 | 8 | EFO_0004611, EFO_0007800 | |
| Disease | X-21448 measurement | 8.03e-16 | 10 | 107 | 7 | EFO_0800816 | |
| Disease | X-23974 measurement | 8.03e-16 | 10 | 107 | 7 | EFO_0800867 | |
| Disease | p-cresol glucuronide measurement | 5.27e-15 | 12 | 107 | 7 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.14e-14 | 13 | 107 | 7 | EFO_0802007 | |
| Disease | xanthurenate measurement | 9.23e-14 | 29 | 107 | 8 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.25e-13 | 30 | 107 | 8 | EFO_0600017 | |
| Disease | angiopoietin-related protein 1 measurement | 2.08e-13 | 18 | 107 | 7 | EFO_0801382 | |
| Disease | tissue factor measurement | 7.53e-13 | 21 | 107 | 7 | EFO_0010623 | |
| Disease | pregnenetriol sulfate measurement | 8.98e-13 | 11 | 107 | 6 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 8.98e-13 | 11 | 107 | 6 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 3.32e-12 | 13 | 107 | 6 | EFO_0800587 | |
| Disease | X-21441 measurement | 2.36e-11 | 17 | 107 | 6 | EFO_0800814 | |
| Disease | serum N-desmethylclozapine measurement | 3.17e-11 | 8 | 107 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 3.17e-11 | 8 | 107 | 5 | EFO_0600038 | |
| Disease | urate measurement, spine bone mineral density | 3.78e-11 | 58 | 107 | 8 | EFO_0004531, EFO_0007701 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 8.15e-10 | 5 | 107 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 8.15e-10 | 5 | 107 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 8.15e-10 | 5 | 107 | 4 | EFO_0801853 | |
| Disease | cholelithiasis | 1.16e-09 | 88 | 107 | 8 | EFO_0004799 | |
| Disease | X-21339 measurement | 5.67e-09 | 7 | 107 | 4 | EFO_0800808 | |
| Disease | gallstones | 5.98e-09 | 108 | 107 | 8 | EFO_0004210 | |
| Disease | thyroxine measurement | 2.24e-08 | 83 | 107 | 7 | EFO_0005130 | |
| Disease | hormone measurement | 2.43e-08 | 84 | 107 | 7 | EFO_0004730 | |
| Disease | blood 4-oxo-retinoic acid measurement | 4.64e-08 | 3 | 107 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 4.64e-08 | 3 | 107 | 3 | EFO_0800043 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 6.73e-08 | 147 | 107 | 8 | DOID:9352 (biomarker_via_orthology) | |
| Disease | vitamin D deficiency | 2.27e-07 | 37 | 107 | 5 | EFO_0003762 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 9.20e-07 | 6 | 107 | 3 | EFO_0800566 | |
| Disease | vitamin D measurement, COVID-19 | 9.58e-07 | 49 | 107 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.13e-06 | 28 | 107 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | vitamin D measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TFDP2 UGT1A4 UNC5CL PEAK1 | 3.90e-06 | 336 | 107 | 9 | EFO_0004631 |
| Disease | indoleacetate measurement | 5.46e-06 | 10 | 107 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 1.29e-05 | 13 | 107 | 3 | EFO_0800898 | |
| Disease | metabolite measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 LIPF UGT1A9 UGT1A4 UGT1A1 UGT1A3 RIMBP2 | 3.79e-05 | 560 | 107 | 10 | EFO_0004725 |
| Disease | non-high density lipoprotein cholesterol measurement | REPS1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 SSH1 UNC5CL | 5.75e-05 | 713 | 107 | 11 | EFO_0005689 |
| Disease | free androgen index | 6.77e-05 | 374 | 107 | 8 | EFO_0007005 | |
| Disease | prostaglandin reductase 1 measurement | 1.29e-04 | 5 | 107 | 2 | EFO_0801932 | |
| Disease | bilirubin measurement | 2.13e-04 | 442 | 107 | 8 | EFO_0004570 | |
| Disease | focal segmental glomerulosclerosis (implicated_via_orthology) | 2.70e-04 | 7 | 107 | 2 | DOID:1312 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | UGT1A10 UGT1A8 UGT1A7 RC3H1 TRPC6 UGT1A9 RIPK4 GRAMD1B PEAK1 | 4.30e-04 | 619 | 107 | 9 | EFO_0003923, EFO_0004531 |
| Disease | response to ondansetron, QT interval | 7.01e-04 | 11 | 107 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | apolipoprotein B measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 PLCB3 CEACAM20 | 7.02e-04 | 663 | 107 | 9 | EFO_0004615 |
| Disease | ocular hypertension, response to triamcinolone acetonide | 7.57e-04 | 49 | 107 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Pathological accumulation of air in tissues | 8.40e-04 | 12 | 107 | 2 | C0013990 | |
| Disease | dodecanedioate measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0021054 | |
| Disease | nicotine dependence (implicated_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | family history of Alzheimer’s disease | 2.22e-03 | 71 | 107 | 3 | EFO_0009268 | |
| Disease | serum metabolite measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 ABCA7 UGT1A4 UGT1A1 UGT1A3 EPHA10 | 2.31e-03 | 945 | 107 | 10 | EFO_0005653 |
| Disease | Stomach Carcinoma | 2.62e-03 | 21 | 107 | 2 | C0699791 | |
| Disease | otitis media (implicated_via_orthology) | 2.87e-03 | 22 | 107 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | otosclerosis | 3.22e-03 | 81 | 107 | 3 | EFO_0004213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LANNTILVKWLPQND | 346 | P35503 | |
| AQQRTLLWNQGSTLP | 666 | Q9BWT7 | |
| QSLAQNLGIQWEPSS | 431 | O75077 | |
| WLPQKNAAQFLLSTN | 101 | P63151 | |
| QSVNVQWFLSGQPLL | 281 | Q6UY09 | |
| NLLQPQALNAWRDLT | 631 | Q9HAR2 | |
| TQWNTCLPLLQHNLR | 386 | Q8IYW2 | |
| PLLSQAQWNENSLVS | 16 | B6SEH9 | |
| QAGQCILLLRIQNPW | 251 | Q9HC96 | |
| VLQTQDQLWASLSNP | 4296 | Q96M86 | |
| RLINQFNDPSNLTTW | 796 | Q9Y4B4 | |
| PWTQNQQKLLELALQ | 496 | Q96KC8 | |
| FAQAQQQLPLESLGW | 41 | P32970 | |
| LPQSQTEWAQLLESQ | 671 | Q3KR37 | |
| TVPWLQGLICNVNNT | 66 | Q8IZY2 | |
| LQHQNPQQLSSNLWA | 171 | Q5TC82 | |
| ALDDPSSLIQLQQIW | 121 | Q7Z444 | |
| NLQLRQLQPASELWS | 36 | Q9H1A4 | |
| LLAQQAWPSGTQQIL | 701 | Q9H2X6 | |
| QNKLLANLLWNCFPS | 216 | Q8IV33 | |
| QLNQQLWSLIPNNDV | 26 | Q49AS3 | |
| NWISNLPNNSLGFIL | 106 | Q5VYY2 | |
| SKQSLIDWNNPAIIN | 286 | Q5VYK3 | |
| PLLSQAQWNENSLVS | 16 | B6SEH8 | |
| LLASATNWISNLPNN | 86 | P07098 | |
| TNWISNLPNNSLAFI | 91 | P07098 | |
| CPSLVQRNTLLQNWL | 1681 | Q9H792 | |
| PNLCLQNSEWLLLDQ | 91 | Q6NT32 | |
| SFQEVWLPINQNLDL | 706 | P59047 | |
| WLPINQNLDLIASSF | 711 | P59047 | |
| QVPLQAWQLSCLANL | 86 | Q96KJ4 | |
| PNNLLNDWSQKLNSL | 421 | O00232 | |
| VCNVLEPNQDNWLQT | 76 | Q5JZY3 | |
| SNWGLNLLQEENVIP | 936 | Q6R327 | |
| WLSDNQSQPLLTFQT | 386 | Q9BTT6 | |
| YWLPLLQNITISQNS | 1056 | Q96JM4 | |
| NWLTLAEQSLNIASP | 6456 | Q9UPN3 | |
| QDIVTANPWNTIALL | 296 | Q9H813 | |
| QWCLQGLPLQSNEVT | 4191 | Q5VST9 | |
| QPLGQAWLQLLDTAQ | 116 | Q96BZ4 | |
| LDTNQAPNWTGLQTL | 16 | Q2TBC4 | |
| PQLFWNVGCQLVALN | 661 | Q01970 | |
| PLSNNVETWLNDLAL | 1491 | Q8NCM8 | |
| PKSNLIQQWLSQQSD | 171 | Q6YHK3 | |
| LLCLQDPNNKSNWNV | 951 | Q9Y4C1 | |
| QIFNLQIVNWPESLT | 711 | Q9P2K1 | |
| GKWVQLQLAESQPNL | 36 | Q6ZP82 | |
| IQDCSQWNVLPTQLL | 51 | Q9NZD1 | |
| QSSLPQAQLASIWNL | 251 | Q15811 | |
| MNWLLCQESLQAPSQ | 396 | Q7Z388 | |
| SLDWALILPLGNQSQ | 596 | Q9UEF7 | |
| LCEQQPIFQNLWKNL | 511 | Q8IWT3 | |
| IPWVLEQILCLQQQQ | 211 | Q9UJQ4 | |
| WNLQGLPNDDLSIQN | 3576 | Q8TE73 | |
| LLQDLQSGQCLQLWD | 506 | Q8NAC3 | |
| TGTPIQNNLQELWSL | 256 | Q2NKX8 | |
| PWRSLSSNLVNIDQN | 521 | O14829 | |
| QAQTLVLTQTPLVWQ | 146 | Q5VT03 | |
| QAQTLILTQAPLVWQ | 96 | A1L443 | |
| QAQTLILTQAPLVWQ | 96 | Q5VZR2 | |
| NQWGLQPRSLLLQAA | 36 | P82914 | |
| NITQISAQLSWLPTN | 401 | O15034 | |
| SLNQTWPELNQSSEQ | 406 | Q96D71 | |
| NFNNWVTLLSQLPLL | 66 | Q14542 | |
| QNLLSPVNCWYLLLN | 91 | Q7Z6B7 | |
| QAPLNQNWVLLCFLL | 191 | Q96RI9 | |
| FLELAQQLGVNPWNT | 196 | Q2M2I3 | |
| EAWAQLSPALLQQQL | 291 | Q6P5W5 | |
| NVLSPVNCWNLLLNQ | 91 | P0DJJ0 | |
| NVLSPVNCWNLLLNQ | 91 | P0DMP2 | |
| SQQLWGLAQQLVDPA | 256 | Q9UIF7 | |
| CAKWLLLNNANPNLS | 501 | P57078 | |
| WIGLPTNSAQECQNL | 206 | Q14188 | |
| PSWLNQGLLLNSTQS | 356 | Q14188 | |
| WGQLPTQLDQNLLNS | 601 | Q8WYL5 | |
| EQLLSLWLEDQSQPN | 91 | B2RD01 | |
| SSLNWPQLENIGNFI | 76 | Q15417 | |
| IATEQQSWNLNNLLP | 266 | Q14690 | |
| QSWNLNNLLPGLVVK | 271 | Q14690 | |
| WIGLPTNSAQECQNL | 191 | Q14186 | |
| DLWNLQALPQNAPLC | 216 | Q96MN9 | |
| NLANNTILVKWLPQN | 341 | Q9HAW8 | |
| ANIQGSITLNLPNCW | 316 | Q7Z2H8 | |
| DLSNADQIPQQTAWN | 396 | Q13905 | |
| APSFLNSVLNQLNWA | 1026 | Q5XPI4 | |
| NASAPDQLSLALAWN | 476 | Q9HCF6 | |
| QVLPFLTSSQQWQSL | 46 | A6NE52 | |
| RDNTQLLINQLWQLP | 66 | Q15050 | |
| NVLSPVNCWNLLLNQ | 91 | O75044 | |
| ANNTILVKWLPQNDL | 346 | P22309 | |
| NNTPCALQWALTNEQ | 271 | Q8IV45 | |
| LANNTILVKWLPQND | 346 | P35504 | |
| QENWLLNSNIPLETR | 236 | Q6N022 | |
| NRWINNASLQPTLSA | 1011 | Q8WWQ8 | |
| SLQFNWKAPLNVNLI | 1671 | P08922 | |
| LPSYWCSQQRLNQQL | 6 | Q9BT92 | |
| SLWPGQALSLQVEQL | 26 | P19623 | |
| WRQQLPTFLQQTQIS | 456 | Q8IYU4 | |
| NLANNTILVKWLPQN | 341 | O60656 | |
| NSLLLWNVFDLNTPV | 261 | Q6PJI9 | |
| TQNQWASLDPAQRAL | 21 | Q6ZSS3 | |
| QELNDQIGLWLSPNF | 541 | P86452 | |
| FVAQPNCQQLLATLW | 301 | Q9UL62 | |
| PNCQQQLLSIWYENL | 381 | Q9Y210 | |
| WPSHQLLTNQLQRLC | 616 | Q13769 | |
| DLQNWPRANITLQVS | 1181 | O75093 | |
| NFSDQPNLTQWIRTI | 1236 | Q8IWV8 | |
| NRWIQQNLQCLLLDS | 151 | Q6WRX3 | |
| TLEEWQLLNPTQKNL | 16 | Q86T29 | |
| LTQALAQSGQQLEWP | 91 | P19971 | |
| NLANNTILVKWLPQN | 341 | Q9HAW7 | |
| QLLWTRQDTQLPQES | 16 | Q5JNZ3 | |
| NSSLFALQNLQPWAE | 256 | O43763 | |
| NLANNTILVKWLPQN | 341 | Q9HAW9 | |
| WQIDLQPLLNSGQDL | 706 | Q5TIE3 | |
| LANNTILVKWLPQND | 346 | P22310 | |
| IWIQTGVQLAPAQNL | 161 | Q86YQ2 | |
| LIASASNWICNLPNN | 86 | Q5VXJ0 | |
| SNWICNLPNNSLAFL | 91 | Q5VXJ0 |